Grupo IMO Receives €20M Equity Investment from Nazca Capital

Grupo IMO, a Spanish provider of radiotherapy services for the treatment of cancer, has received an approximate €20m investment from Nazca Capital.

Nazca, which made the investment through its Fund Nazca III, will take a majority stake in the company through the direct acquisition of shares to several shareholders as well as through the subscription of a significant capital increase. Doctor José Samblas, Chairman and Founder of Grupo IMO together with key members of the management team have participated in the deal reinvesting most of their stakes in the company, which intends to use the funds to strengthen its balance sheet in order to continue to grow.
The transaction is still subject to the approval by Spanish anti-trust authorities.

Founded 20 years ago, Grupo IMO operates a network of 11 owned centres specialized exclusively in offering radiotherapy services and located in different regions of Spain including Castilla La Mancha, Murcia, Madrid, Alicante and Seville. The company currently has 16 linear accelerators for advanced treatments, including equipments for robotized surgery (Cyberknife) or two Tomotherapy units. It has a team of 200 professionals.



Join the discussion